MFDS Holds 'Pharmaceutical Clinical Trial Policy Briefing'
[Asia Economy Reporter Lee Gwan-ju] The Ministry of Food and Drug Safety announced on the 23rd that it will hold the '2023 Pharmaceutical Clinical Trial Policy Briefing' for domestic clinical trial stakeholders at the aT Center in Seocho-gu, Seoul.
At this briefing, the following will be covered: ▲2023 pharmaceutical clinical trial policy directions ▲recent amendments to laws related to clinical trials ▲basic plan for clinical trial status survey ▲review procedures of the Central Institutional Review Board (Central IRB).
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Not Even Buying a Bottle of Water": BTS Fans Outraged Over Price-Gouging by Busan Accommodations
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The briefing materials will be made available later on the Ministry of Food and Drug Safety website. The Ministry stated, "This policy briefing is expected to enhance the understanding of clinical trial policy directions among pharmaceutical companies and researchers, assist in preparing materials necessary for clinical trial plan approval, and help ensure safety management during clinical trial execution." They added, "We will continue to create opportunities for communication with the industry."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
